These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease. Puig A; McElligott S; Bergquist H; Doshi JA Am J Geriatr Pharmacother; 2010 Dec; 8(6):571-82. PubMed ID: 21356506 [TBL] [Abstract][Full Text] [Related]
4. [A case of successful use of broncholytic nebulizer therapy in the complex treatment of chronic obstructive lung disease with a severe course in an elderly patient]. Ovcharenko SI; Malova EV; Morozova NV; Iashunskaia NI; Peredel'skaia OA Ter Arkh; 2002; 74(9):85-7. PubMed ID: 12418130 [No Abstract] [Full Text] [Related]
5. [Combination therapy with inhaled bronchodilators in chronic obstructive pulmonary disease]. Shen N; Cai BQ; Yao WZ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):766-7. PubMed ID: 19080604 [No Abstract] [Full Text] [Related]
6. [Chronic obstructive pulmonary disease]. Finnish Association of Pulmonologists Duodecim; 2003; 119(24):2523-4. PubMed ID: 14870520 [No Abstract] [Full Text] [Related]
8. Current trends in the management of chronic obstructive pulmonary disease. Liam CK Med J Malaysia; 2000 Jun; 55(2):285-92; quiz 293. PubMed ID: 19839165 [No Abstract] [Full Text] [Related]
11. After UPLIFT: smoking cessation remains the best intervention in smokers with COPD. Chen-Yuan C Int J Tuberc Lung Dis; 2009 Feb; 13(2):151-2. PubMed ID: 19146740 [No Abstract] [Full Text] [Related]
12. [Therapy without success. Every 3d powder inhaler is used improperly (interview by Maria Weiss)]. Wieshammer S MMW Fortschr Med; 2007 Nov; 149(48):8. PubMed ID: 18161431 [No Abstract] [Full Text] [Related]
13. Spending decisions for tobacco-related disease treatment and tobacco control: an example and a solution. Thomson G; Wilson N N Z Med J; 2005 Feb; 118(1210):U1337. PubMed ID: 15776107 [No Abstract] [Full Text] [Related]
16. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations. Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528 [TBL] [Abstract][Full Text] [Related]
17. New treatments for COPD. Barnes PJ Nat Rev Drug Discov; 2002 Jun; 1(6):437-46. PubMed ID: 12119745 [TBL] [Abstract][Full Text] [Related]
18. The challenge of differentiating asthma from chronic obstructive pulmonary disease. Hanania NA Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6. PubMed ID: 18564559 [No Abstract] [Full Text] [Related]
19. [Bronchodilating long-acting drugs in the treatment of stable chronic obstructive pulmonary disease. Analysis of the latest data]. Stepanian IE Ter Arkh; 2006; 78(11):92-5. PubMed ID: 17195539 [No Abstract] [Full Text] [Related]
20. N.U.A.G.E.S: a survey of nebulisation practice in France with regard to ERS guidelines. de Monte M; Scruignec J; Dubus JC; Chaumuzeau JP; Dautzenberg B; Dessanges JF; Becquemin MH; Diot P; Respir Med; 2007 Dec; 101(12):2561-5. PubMed ID: 17869081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]